Morgan Stanley Issues Positive Forecast for Globus Medical (NYSE:GMED) Stock Price

Globus Medical (NYSE:GMED – Free Report) had its target price lifted by Morgan Stanley from $74.00 to $83.00 in a report released on Monday morning,Benzinga reports. Morgan Stanley currently has an equal weight rating on the medical device company’s stock. Several other research firms have also recently weighed in on GMED. Stifel Nicolaus raised their […]

Leave a Reply

Your email address will not be published.

Previous post Boston election ballot mess raises concerns about city’s ability to handle ranked-choice voting
Next post Mind Medicine (MindMed) (NASDAQ:MNMD) Receives Buy Rating from HC Wainwright